OptiNose, Inc. (OPTN)
9.60
-0.11 (-1.13%)
Inactive · Last trade price
on May 20, 2025
OptiNose Employees
As of December 31, 2024, OptiNose had 128 total employees, including 127 full-time and 1 part-time employees. The number of employees decreased by 4 or -3.03% compared to the previous year.
Employees
128
Change (1Y)
-4
Growth (1Y)
-3.03%
Revenue / Employee
$639,500
Profits / Employee
-$233,516
Market Cap
97.22M
Employees Chart
OPTN News
- 5 weeks ago - OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN - Business Wire
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders - GlobeNewsWire
- 2 months ago - Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call - GlobeNewsWire
- 2 months ago - Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) - GlobeNewsWire
- 5 months ago - Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewsWire
- 5 months ago - Optinose Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 6 months ago - Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 7 months ago - OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript - Seeking Alpha